Core Lab Reports Second Quarter 2020 Results From Continuing Operations:

Go back to Core Lab Reports Second Quarter 2020 Results From Continuing Operations:

Core Laboratories (CLB) PT Raised to $26 at Cowen

July 24, 2020 8:06 AM EDT

Cowen analyst Marc Bianchi raised the price target on Core Laboratories (NYSE: CLB) to $26.00 (from $24.00) while maintaining a Market Perform rating.

... More

Core Laboratories (CLB) PT Raised to $27 at RBC Capital

July 23, 2020 1:58 PM EDT

RBC Capital analyst Kurt Hallead raised the price target on Core Laboratories (NYSE: CLB) to $27.00 (from $24.00) while maintaining an Outperform rating.

The analyst commented, "CLB continues to adhere to its long standing financial tenets of maximizing FCF, ROIC and returning excess... More

Core Laboratories (CLB) Tops Q2 EPS by 4c

July 22, 2020 5:16 PM EDT

Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $115.7 million versus the consensus estimate of $115.35 million.

Industry and Core Lab Outlook:

Although crude-oil prices improved from the lows seen in May, E&P companies further reduced their 2020 capital expenditure plans, especially in... More